VALOR – Valsartan/HCTZ Combination Therapy in Patients With Moderate to Severe Systolic Hypertension
The results of the Valsartan/HCTZ Combination Therapy in Patients With Moderate to Severe Systolic Hypertension (VALOR) study [1] show that valsartan 160 mg once daily is safe and effective in older ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Valsartan (Starval (160 mg)) is an angiotensin II ...
Concomitant therapy with the following medications was prohibited: other ARBs, angiotensin-converting enzyme (ACE) inhibitors, β-adrenergic antagonists, calcium-channel blockers, any other ...
This was a multi-center, open-label, parallel-group trial. Eligible patients were enrolled at the central registration center and were randomized to receive either of two doses of valsartan (80 or 160 ...
After 4 weeks of treatment with aliskiren 150 mg or valsartan 160 mg alone or in combination, statistically significant reductions in msDBP and msSBP were seen in all treatment groups vs placebo, ...
Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/160 mg/12.5 mg, 90-count bottles, lot. Nos. 20x006 and 21x006, expiration 11/2018. Amlodipine, Valsartan, and Hydrochlorothiazide Tablets ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.
Please provide your email address to receive an email when new articles are posted on . “In many individuals, [hypertrophic cardiomyopathy] is oftentimes genetic, caused by pathogenic variants in ...
Health Canada has issued a recall advisory of a commonly used medication to treat high blood pressure because of fears an impurity found in the drugs may cause cancer with long-term exposure. The ...
FDA has approved Valturna (aliskiren and valsartan) tablets, which the drug’s maker, Novartis, of East Hanover, N.J., said is the first and only product to target two key points in the renin ...
Mylan Pharmaceuticals ULC is voluntarily recalling four lots of Mylan-Valsartan tablets (40 mg, 80 mg, 160 mg and 320 mg strength) after testing found low levels of an impurity, N-nitrosodiethylamine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results